$2.62
5.07% yesterday
NYSE, Dec 30, 10:10 pm CET
ISIN
US67080N1019
Symbol
NUVB
Sector
Industry

Nuvation Bio Inc - Ordinary Shares - Class A Target price 2024 - Analyst rating & recommendation

Nuvation Bio Inc - Ordinary Shares - Class A Classifications & Recommendation:

Buy
100%

Nuvation Bio Inc - Ordinary Shares - Class A Price Target

Target Price $6.00
Price $2.62
Potential
Number of Estimates 4
4 Analysts have issued a price target Nuvation Bio Inc - Ordinary Shares - Class A 2025 . The average Nuvation Bio Inc - Ordinary Shares - Class A target price is $6.00. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 5 analysts: 5 Analysts recommend Nuvation Bio Inc - Ordinary Shares - Class A to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Nuvation Bio Inc - Ordinary Shares - Class A stock has an average upside potential 2025 of . Most analysts recommend the Nuvation Bio Inc - Ordinary Shares - Class A stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Million $ 0.00 2.19

5 Analysts have issued a sales forecast Nuvation Bio Inc - Ordinary Shares - Class A 2024 . The average Nuvation Bio Inc - Ordinary Shares - Class A sales estimate is

$2.2m
Unlock
. This is
1.50% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$2.2m 1.85%
Unlock
, the lowest is
$2.2m 0.09%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $0.0
2025
$8.7m 295.92%
Unlock
2026
$50.6m 483.13%
Unlock
2027
$162m 220.45%
Unlock
2028
$295m 81.91%
Unlock

2 Nuvation Bio Inc - Ordinary Shares - Class A Analysts have issued a net profit forecast 2024. The average Nuvation Bio Inc - Ordinary Shares - Class A net profit estimate is

$-703m
Unlock
. This is
3.69% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-703m 3.69%
Unlock
, the lowest is
$-703m 3.69%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $-118m 27.08%
2024
$-703m 497.14%
Unlock
2025
$-215m 69.38%
Unlock
2026
$-185m 14.06%
Unlock
2027
$-101m 45.45%
Unlock
2028
$-10.1m 90.00%
Unlock

Net Margin

2025
-2,479.21% 92.27%
Unlock
2026
-365.37% 85.26%
Unlock
2027
-62.19% 82.98%
Unlock
2028
-3.42% 94.50%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share $ -0.35 -2.09
27.08% 497.14%
P/E negative
EV/Sales 179.59

2 Analysts have issued a Nuvation Bio Inc - Ordinary Shares - Class A forecast for earnings per share. The average Nuvation Bio Inc - Ordinary Shares - Class A <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$-2.09
Unlock
. This is
3.69% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$-2.09 3.69%
Unlock
, the lowest is
$-2.09 3.69%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $-0.35 27.08%
2024
$-2.09 497.14%
Unlock
2025
$-0.64 69.38%
Unlock
2026
$-0.55 14.06%
Unlock
2027
$-0.30 45.45%
Unlock
2028
$-0.03 90.00%
Unlock

P/E ratio

Current -1.27 67.68%
2024
-1.32 3.94%
Unlock
2025
-4.31 226.52%
Unlock
2026
-5.02 16.47%
Unlock
2027
-9.20 83.27%
Unlock
2028
-92.00 900.00%
Unlock

Based on analysts' sales estimates for 2024, the Nuvation Bio Inc - Ordinary Shares - Class A stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

179.59
Unlock
and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of
424.96
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 182.28
2024
179.59 1.48%
Unlock
2025
45.36 74.74%
Unlock
2026
7.78 82.85%
Unlock
2027
2.43 68.79%
Unlock
2028
1.33 45.03%
Unlock

P/S ratio

Current
2024
424.96 1.48%
Unlock
2025
107.33 74.74%
Unlock
2026
18.41 82.85%
Unlock
2027
5.74 68.79%
Unlock
2028
3.16 45.03%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today